Search Results

There are 2128 results for: content related to: A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

  1. You have free access to this content
    The Pharmacology and Therapeutic Use of Dabigatran Etexilate

    The Journal of Clinical Pharmacology

    Volume 53, Issue 1, January 2013, Pages: 1–13, Spinler Sarah

    Version of Record online : 24 JAN 2013, DOI: 10.1177/0091270011432169

  2. Dabigatran etexilate: What do hospitalists need to know?

    Journal of Hospital Medicine

    Volume 7, Issue 3, March 2012, Pages: 262–269, Amer Zeidan, Bishoy Faltas and Michael Streiff

    Version of Record online : 29 NOV 2011, DOI: 10.1002/jhm.996

  3. You have free access to this content
    A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time

    British Journal of Clinical Pharmacology

    Volume 78, Issue 3, September 2014, Pages: 599–609, Paul K. L. Chin, Daniel F. B. Wright, David M. Patterson, Matthew P. Doogue and Evan J. Begg

    Version of Record online : 21 AUG 2014, DOI: 10.1111/bcp.12364

  4. You have free access to this content
    Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin

    British Journal of Clinical Pharmacology

    Volume 74, Issue 3, September 2012, Pages: 490–500, Sebastian Härtter, Michael Koenen-Bergmann, Ashish Sharma, Gerhard Nehmiz, Ute Lemke, Wolfgang Timmer and Paul A. Reilly

    Version of Record online : 6 AUG 2012, DOI: 10.1111/j.1365-2125.2012.04218.x

  5. An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis

    The Journal of Clinical Pharmacology

    Volume 54, Issue 8, August 2014, Pages: 901–909, Jo-Anne S. Wilson, Kerry B. Goralski, Steven D. Soroka, Matthew Morrison, Paula Mossop, Lekha Sleno, Yan Wang and David R. Anderson

    Version of Record online : 28 MAY 2014, DOI: 10.1002/jcph.335

  6. Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, With Coadministration of Digoxin

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 243–250, Dr Joachim Stangier, Ms Hildegard Stähle, Dr Karin Rathgen, Dr Willy Roth, Dr Kathrin Reseski and Dr Thomas Körnicke

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010393342

  7. You have full text access to this OnlineOpen article
    Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation

    International Journal of Clinical Practice

    Volume 67, Issue 6, June 2013, Pages: 516–526, K. Huber, S. J. Connolly, A. Kher, F. Christory, G.-A. Dan, R. Hatala, R. G. Kiss, B. Meier, B. Merkely, B. Pieske, T. Potpara, J. Stępińska, N. Vene Klun, D. Vinereanu and P. Widimský

    Version of Record online : 5 APR 2013, DOI: 10.1111/ijcp.12147

  8. You have free access to this content
    Direct thrombin inhibitors

    British Journal of Clinical Pharmacology

    Volume 72, Issue 4, October 2011, Pages: 581–592, Catherine J. Lee and Jack E. Ansell

    Version of Record online : 9 SEP 2011, DOI: 10.1111/j.1365-2125.2011.03916.x

  9. You have free access to this content
    The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

    British Journal of Clinical Pharmacology

    Volume 64, Issue 3, September 2007, Pages: 292–303, Joachim Stangier, Karin Rathgen, Hildegard Stähle, Dietmar Gansser and Willy Roth

    Version of Record online : 15 MAY 2007, DOI: 10.1111/j.1365-2125.2007.02899.x

  10. Thrombin inhibitors: surgical considerations and pharmacology

    ANZ Journal of Surgery

    Volume 83, Issue 4, April 2013, Pages: 215–221, Omar Breik, Rami Tadros and Peter Devitt

    Version of Record online : 6 FEB 2013, DOI: 10.1111/ans.12078

  11. Enhanced elimination of dabigatran: Identifying the appropriate patient for the use of continuous venovenous hemodialysis instead of intermittent hemodialysis—A simulation analysis

    The Journal of Clinical Pharmacology

    Volume 56, Issue 5, May 2016, Pages: 597–608, Karl-Heinz Liesenfeld, Fredrik Gruenenfelder and Andreas Clemens

    Version of Record online : 5 NOV 2015, DOI: 10.1002/jcph.620

  12. You have free access to this content
    Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease

    Arthritis & Rheumatism

    Volume 63, Issue 5, May 2011, Pages: 1416–1425, Galina S. Bogatkevich, Anna Ludwicka-Bradley, Paul J. Nietert, Tanjina Akter, Joanne van Ryn and Richard M. Silver

    Version of Record online : 27 APR 2011, DOI: 10.1002/art.30255

  13. New Anticoagulants for Prevention of Stroke in Patients with Atrial Fibrillation

    Journal of Cardiovascular Electrophysiology

    Volume 22, Issue 8, August 2011, Pages: 948–955, JUAN F. VILES-GONZALEZ, VALENTIN FUSTER and JONATHAN L. HALPERIN

    Version of Record online : 10 JUN 2011, DOI: 10.1111/j.1540-8167.2011.02104.x

  14. You have free access to this content
    Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation

    Clinical Cardiology

    Volume 37, Issue 1, January 2014, Pages: 32–47, Irene Savelieva and A. John Camm

    Version of Record online : 19 NOV 2013, DOI: 10.1002/clc.22204

  15. You have free access to this content
    Proceedings of the Thrombosis and Hemostasis summit of North America: Research abstracts

    American Journal of Hematology

    Volume 87, Issue S1, May 2012, Pages: S146–S200,

    Version of Record online : 10 APR 2012, DOI: 10.1002/ajh.23168

  16. You have free access to this content
    Acute Stroke Management in Patients Taking Dabigatran

    CNS Neuroscience & Therapeutics

    Volume 18, Issue 8, August 2012, Pages: 616–622, Raf Brouns, Robbert-Jan Van Hooff, Ann De Smedt, Maarten Moens, Sylvie De Raedt, Maarten Uyttenboogaart, Gert-Jan Luijckx, Kristin Jochmans and Jacques De Keyser

    Version of Record online : 25 APR 2012, DOI: 10.1111/j.1755-5949.2012.00329.x

  17. You have free access to this content
    Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue 10, October 2015, Pages: 1790–1798, C. Chai-Adisaksopha, C. Hillis, W. Lim, K. Boonyawat, K. Moffat and M. Crowther

    Version of Record online : 29 SEP 2015, DOI: 10.1111/jth.13117

  18. Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment

    The Journal of Clinical Pharmacology

    Volume 48, Issue 12, December 2008, Pages: 1411–1419, Dr Joachim Stangier, Hildegard Stähle, Dr Karin Rathgen, Dr Willy Roth and Dr Kasra Shakeri-Nejad

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008324179

  19. Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation

    Journal of the American Association of Nurse Practitioners

    Volume 27, Issue 4, April 2015, Pages: 190–196, Katie A. Scott and Karen A. Amirehsani

    Version of Record online : 25 JUL 2014, DOI: 10.1002/2327-6924.12161

  20. You have free access to this content
    Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor

    Journal of Thrombosis and Haemostasis

    Volume 8, Issue 4, April 2010, Pages: 790–798, C. T. AMMOLLO, F. SEMERARO, F. INCAMPO, N. SEMERARO and M. COLUCCI

    Version of Record online : 17 JAN 2010, DOI: 10.1111/j.1538-7836.2010.03739.x